In the first episode of 2024, Shobita and Jack reflect on the first CRISPR therapy approved by drug regulators around the world, for sickle cell disease. We also talk about the safety issues plaguing Boeing, and the Post Office scandal roiling the UK and why it matters for regulating AI. And, we...

This month, Shobita and Jack reflect on the recent COP meeting in the United Arab Emirates, recent AI news including the Biden Administration's Executive Order, the UK summit, and the fates of the two Sams: Altman and Bankman-Fried. And they chat with Sarah de Rijcke, Professor in Science,...